News & Events

NEWS
EVENTS
Publications

NEWS

  • Metabomed joins Merck Serono Israel Bioincubator

    Metabomed will be financed by a syndicate led by MS Ventures together with Boehringer Ingelheim Venture Fund, Pontifax LLC and the Technion Research and Development Foundation Metabomed brings together three world-leading researchers to focus on drug discovery in the field of novel targets in cancer metabolism.

    Read More
  • Cancer Metabolism Company Metabomed Completes $18 Million Series A Financing

    Existing Investors MS Ventures, Boehringer Ingelheim Venture Fund, Pontifax LLC and the Technion Research and Development Foundation are joined by Pfizer Inc. and Arkin Holdings Simone Botti, Head of MS Ventures Israel BioIncubator Fund, will join the company as full time CEO.

    Read More

In The Press

Publications